 | Up a level |
Hübner, Simona T; Bertoli, Raffaela; Rätz Bravo, Alexandra E; Schaueblin, Martina; Haschke, M.; Scherer, Kathrin; Ceschi, Alessandro; Leuppi-Taegtmeyer, Anne B (2018). C-Reactive Protein and Procalcitonin in Case Reports of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. International archives of allergy and immunology, 176(1), pp. 44-54. Karger 10.1159/000487670
Liakoni, Evangelia; Rätz Bravo, Alexandra E; Krähenbühl, Stephan (2015). Hepatotoxicity of New Oral Anticoagulants (NOACs). Drug safety, 38(8), pp. 711-720. Springer 10.1007/s40264-015-0317-5
Liakoni, Evangelia; Rätz Bravo, Alexandra E; Terracciano, Luigi; Heim, Markus; Krähenbühl, Stephan (2014). Symptomatic hepatocellular liver injury with hyperbilirubinemia in two patients treated with rivaroxaban. JAMA Internal Medicine, 174(10), pp. 1683-1686. American Medical Association 10.1001/jamainternmed.2014.3912
Franz, Carmen C; Hildbrand, Carole; Born, Christa; Egger, Sabin; Rätz Bravo, Alexandra E; Krähenbühl, Stephan (2013). Dose adjustment in patients with liver cirrhosis: impact on adverse drug reactions and hospitalizations. European journal of clinical pharmacology, 69(8), pp. 1565-73. Berlin: Springer 10.1007/s00228-013-1502-z
Franz, Carmen C; Egger, Sabin; Born, Christa; Rätz Bravo, Alexandra E; Krähenbühl, Stephan (2012). Potential drug-drug interactions and adverse drug reactions in patients with liver cirrhosis. European journal of clinical pharmacology, 68(2), pp. 179-88. Berlin: Springer 10.1007/s00228-011-1105-5
